Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observatio...
Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Opioids provide effective analgesia for moderate-to-severe, chronic pain. Transdermal buprenorphine (TDB) is available in the UK as weekly, lower-dose (5–20 μg/h) patches and twice-weekly, higher dose (35–70 μg/h) patches. This prospective, observational, multicenter study of patients with various chronic pain conditions assessed the...
Alternative Titles
Full title
Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4720699
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4720699
Other Identifiers
ISSN
1178-1653
E-ISSN
1178-1661
DOI
10.1007/s40271-015-0151-y
